Home
About
Publications Trends
Recent Publications
Expert Search
Archive
ncrp report no. 170
What is NCRP Report No. 170?
NCRP Report No. 170, titled "Second Primary Cancers and Cardiovascular Disease After Radiation Therapy," is a comprehensive document published by the
National Council on Radiation Protection and Measurements
(NCRP). The report delves into the risks and mechanisms behind the development of
second primary cancers
and
cardiovascular disease
(CVD) in patients who have undergone
radiation therapy
for an initial cancer diagnosis.
Frequently asked queries:
What is NCRP Report No. 170?
Why is NCRP Report No. 170 Significant?
What are the Key Findings on Second Primary Cancers?
How Does Radiation Therapy Influence Cardiovascular Disease?
What Recommendations Does the Report Provide?
What Future Research Directions are Suggested?
What is Patient Engagement in Cancer Care?
What are the Key Benefits of Using scRNA-seq in Cancer?
How Can Patients Prepare for a PR Test?
How Does 3D Cell Culture Improve Drug Screening?
What Information is Protected Under an NDA?
How Does the Prize Impact Future Research?
Can OTC Drugs Be Used for Pain Management in Cancer?
What Is the Future of Urine Analysis in Cancer Care?
How Can Friends and Family Support a Smoker in Quitting?
How Do Genetics Play a Role in Cancer Risk?
Why Are These Tests Important?
What is the relationship between the ICR and The Royal Marsden Hospital?
How is High-Performance Computing (HPC) Utilized?
How Do Toxins Cause Cancer?
Follow Us
Facebook
Linkedin
Youtube
Instagram
Top Searches
Brain Tumor
Breast cancer
cancer
Cancer Genomics
Chemotherapy
hepatocellular carcinoma
Nanotechnology
Non-Hodgkin’s Lymphoma
Partnered Content Networks
Relevant Topics
4D Segmentation
Alopecia
Atlas-based Segmentation
Automated Segmentation
B-cell malignancies
biomarkers
Brain Tumor
Brain Tumor Segmentation
Breast cancer
cancer
Cancer Genome Atlas
Cancer genomics
Cancer treatment
CAR T-cell therapy
cell adhesion
cell migration
chemotherapy
Chromatin remodeling genes
CIAbimatoprost
Combination therapy
Copy number variations
cytokine release syndrome
Deep Learning
diffuse large B-cell lymphoma
docetaxel-cyclophosphamide
Drug delivery
epirubicin-cyclophosphamide
extracellular matrix
Genetic alteration
Glioblastoma
Gold nanoparticles
Hepatocellular carcinoma
High Tumor
image-guided radiotherapy
Imaging Techniques
Immunotherapy
Integrative genomics
integrin inhibitors
Integrins
Keratinocyte
Lipid-based nanoparticles
liver cancer
Machine Learning
Magnetic Resonance Imaging
metastasis
methyltransferase
MRI
Multi-modal Imaging
Mutual exclusivity analysis
Nanoparticles
Nanotechnology
neoadjuvant radiotherapy
neurotoxicity
Next-generation sequencing
nnovative Biomarkers
Non-Hodgkin’s lymphoma
Novel Biomarkers for Brain Tumors
Novel Chemotherapy
Oncogenic transcription factors
oncological diseases
paclitaxel
Personalized medicine
Photobiomodulation therapy
Polymeric nanoparticles
portal vein tumor thrombus
Probabilistic Models
radiotherapy
refractory lymphoma
relapsed lymphoma
Silver nanoparticles
stereotactic body radiation therapy
Targeted therapy
Tolerability
transarterial chemoembolization
tumor microenvironment
tumor progression
Voltage-gated sodium channels
Subscribe to our Newsletter
Stay updated with our latest news and offers related to Cancer.
Subscribe